WuXi PharmaTech Inc. (WX) Tops Q1 EPS by 5c; Guides Q2 Sales
Tweet
Share
E-mailGet Alerts WX Hot Sheet
Join SI Premium – FREE
WuXi PharmaTech Inc. (NYSE: WX) reported Q1 EPS of $0.29, $0.05 better than the analyst estimate of $0.24. Revenue for the quarter came in at $93.6 million versus the consensus estimate of $92.49 million.
Sees Q2 2011 revenue of $97-$99 million, versus the consensus of $99.1 million.
Sees Q2 2011 revenue of $97-$99 million, versus the consensus of $99.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
